Stimulation of Ca2+ efflux from fura-2-loaded platelets activated by thrombin or phorbol myristate acetate  by Pollock, W.K. et al.
Volume 210, number 2, 132-136 FEB 04319 January 1987 
Stimulation of Ca2+ efflux from fura-2-loaded platelets 
activated by thrombin or phorbol myristate acetate 
W.K. Pollock, S.O. Sage+ and T.J. Rink* 
Biochemistry Department, AFRC, IAP, Babraham. Cambridge, +Physiological Laboratory, University of Cambridge, 
Cambridge and *Smith Kline and French Research Ltd, The Frythe, Welwyn, England 
Received 31 October 1986 
We investigated the restoration of [Ca2+], in fura-2-loaded human platelets following discharge of internal 
Ca2+ stores in the absence of external Ca2+. After stimulation by thrombin [Caz+], returned from a peak 
level of 0.6 PM to resting levels within 4 min. When ionomycin discharged the internal stores the recovery 
was slower with [Caz+], still elevated at around 0.5 PM after 5 min. Thrombin added shortly after ionomycin 
could accelerate the recovery of [Caz+], and restore resting levels within 5 min, an effect that was mimicked 
by phorbol-12-myristate-13-acetate (PMA). Since the continued presence of ionomycin precluded reuptake 
into the internal stores we conclude that thrombin and PMA stimulate Caz+ efflux, perhaps via protein 
kinase C actions on a plasma membrane Caz+ pump. 
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1. INTRODUCTION 
In blood platelets agonist-induced rises in 
cytosolic free Ca2+ ([Ca’+]i) are often transient or 
have a phasic component [l-3], even in the con- 
tinued presence of the agonist. In the absence of 
external Ca2+ the recovery phase of a [Ca”]i signal 
may reflect a desensitisation of Ca2+ mobilisation 
followed by extrusion of Ca2+ from the cell and 
reuptake into internal stores, or there could be per- 
sistent mobilisation with stimulated Ca2+ efflux 
and/or re-uptake, or some combination of these 
possibilities. 
We present here experiments using 
fura-2-loaded human platelets suspended in the 
absence of external Ca2+ which allowed us to 
analyse the contribution of extrusion and re- 
uptake of Ca2+ following thrombin stimulation, 
and the influence of thrombin or phorbol 
myristate acetate (PMA) on Ca2+ extrusion. The 
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initial observation was that, in the absence of ex- 
ternal Ca2+, recovery of [Ca2’]i following throm- 
bin stimulation was faster and more complete than 
that following discharge of internal stores by the 
Ca2+ ionophore ionomycin. The continued 
presence of ionomycin is expected to prevent rese- 
questration into internal storage pools by releasing 
Ca2+ as soon as it is taken up. In addition, 
ionomycin has a relatively low affinity for Ca2+, 
EG0 of approx. 50 FM [Ca2’], for an elevation of 
[Ca2+]i in quinZloaded human platelets (Simpson, 
A.W. and Rink, T.J., unpublished). Thus 
ionomycin is ineffective in translocating Ca2+ from 
the cytosol where [Ca2+]i is normally below 
micromolar. In the presence of ionomycin 
recovery of an elevated [Ca2+]i is presumably 
therefore due almost entirely to Ca2+ extrusion. 
Thrombin stimulation of platelets is known to 
activate protein kinase C (PKC) [4,5] as a conse- 
quence of receptor-stimulated generation of 
diacylglycerol. PMA is a pharmacological ac- 
tivator of PKC [6] and is reported to inhibit an 
elevation in [Ca2’], in various cell types [7,8] in- 
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eluding platelets [9]. PMA is also reported to 
stimulate Ca2+ efflux from neutrophils [lo]. Using 
ionomycin-stimulated platelets, the influence of 
thrombin and PMA on Ca2+ efflux could therefore 
be investigated to determine whether such a 
stimulation of extrusion is present in these cells. 
2. EXPERIMENTAL 
boxane formation and 1 mM EGTA was added to 
individual 0.8 ml aliquots of cells to maintain the 
external [Ca2+] below lo-* M. Fura- fluorescence 
was measured at 37°C in a Perkin-Elmer MPF44A 
spectrophotometer with excitation and emission 
wavelengths of 339 and 500 nm, respectively; 
[Ca2+]i was calculated as described [ll] using a 
Ca2+/dye dissociation constant for fura- of 
224 nM. 
Platelet-rich plasma was prepared from freshly 
drawn blood as in [l]. Platelets were then loaded 
with 50-80 rmol fura- cell water by incubating 
platelet-rich plasma for 45 min at 37°C in the 
presence of 3 PM fura- acetoxy methyl ester. The 
cells were then spun down (350 x g, 20 min, 
1%20°C) in the presence of 20 ,ug apyrase/ml, the 
supernatant plasma discarded and the cells 
resuspended in physiological saline containing: 
145 mM NaCl, 5 mM KCI, 1 mM MgS04, 10 mM 
Hepes, 10 mM dextrose (pH 7.4) at 37°C. The cell 
count was 1.5-2 x 10’ platelets/ml. lO/rM in- 
domethacin was present to eliminate any throm- 
The fluorescence records shown are typical of 
replicate (2-4) determinations within the same 
batch of cells; similar results were observed in at 
least 3 different experiments using platelets from 
different donors. 
2.1. Materials 
Fura- acetoxy methyl ester was obtained from 
Molecular Probes (Junction City, OR); 
ionomycin, platelet-activating factor (PAF) and 
human thrombin were from Calbiochem (Cam- 
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Fig.1. Discharge of internal Ca*+ stores by thrombin and ionomycin. Fura- fluorescence from human platelets 
suspended in the presence of 1 mM EGTA and activated by (a) 0.3 U/ml thrombin or (b) 1 pM ionomycin. [Ca’+]r 
values in nM were calculated as described in section 2. 
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3. RESULTS AND DISCUSSION 
In fig.1 fluorescence records are shown from 
fura-Zloaded platelets stimulated by 0.3 U/ml 
thrombin (a) and 1 PM ionomycin (b). Thrombin 
caused a rapid elevation in [Ca2’]r from a resting 
level of just under 100 nM to a peak value of over 
600 nM. Thereafter the [Ca2+]i returned to resting 
levels within 4 min. Ionomycin similarly evoked a 
rapid elevation in [Ca’+]i up to a maximum of 
1.3 PM (fig.lb), but following an initial decline, 
the response to ionomycin decayed much more 
slowly, recovering only to 580 nM after 5 min. The 
elevations in [Ca2’], caused by both thrombin and 
ionomycin are a consequence of Ca2’ mobilisation 
from internal stores since, with 1 mM EGTA pre- 
sent, the external [Ca2’] was less than 1Ch * M. The 
subsequent fall in the signal indicates removal of 
Ca2+ from the cytosol into internal stores or extru- 
sion across the plasma membrane. For thrombin, 
acting through a receptor-operated mechanism, 
both active extrusion and sequestration by 
Ca2+-pumping organelles are expected to con- 
tribute to the recovery of [Ca2+]i. However, with 
ionomycin the observed fall in the [Ca2+]i signal 
can probably occur only by Ca2+ extrusion; the 
continued presence of ionomycin is expected to 
(a) (b) 





‘short-circuit’ sequestering organelles. (For 
reasons outlined in section 1, ionomycin is not ex- 
pected to translocate Ca2+ across the plasma mem- 
brane under the experimental conditions used.) 
The recovery from an elevation in [Ca2+]; in 
response to thrombin (fig.la) could result from 
Ca2+ re-uptake into internal organelles, stimulated 
extrusion, or both. We next examined the effect of 
thrombin on [Ca2+]i elevated by ionomycin as 
shown in fig.2, where re-uptake should have been 
precluded. Fig.2a shows the control response to 
ionomycin; a rapid elevation in [Ca2+]i to 1.3 pM 
followed by a fall to 500 nM after 5 min. Addition 
of thrombin to platelets 60 s after ionomycin 
(fig.2b) caused no further elevation in [Ca’+]i, im- 
plying that the ionomycin had maximally dis- 
charged the thrombin-sensitive Ca2+ pool. How- 
ever, thrombin did stimulate the recovery of the 
[Ca2+]i so that it returned to the basal level within 
4 min. To test our hypothesis that the recovery 
reflected Ca2+ extrusion and not refilling of the in- 
ternal pool we looked at the response to another 
agonist, PAF, capable of discharging Ca2+ from 
internal stores [l]. Fig.2 shows that the addition of 
PAF after the application of ionomycin and 
thrombin did not raise [Ca2+]i, indicating that the 








Fig.2. Stimulation of Ca ‘+ efflux by thrombin. Fura- fluorescence from human platelets suspended in the presence 
of 1 mM EGTA and activated by (a) 1 pM ionomycin (IONO), (b) ionomycin followed by 0.3 U/ml thrombin (THR), 
and (c) thrombin followed by 20 ng/ml platelet activating factor (PAF). 
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dition of PAF after thrombin alone (fig.2c) did 
raise [Ca’+]i, to 250 nM. Thus after thrombin 
alone the internal pool is at least partly refilled im- 
plying that some of the recovery of [Ca*+]i under 
these conditions is due to repletion of the dis- 
chargeable pool. It is worth noting that the recovery 
of [Ca*+]i following thrombin alone (figs la,2c) is 
faster than that seen when thrombin follows iono- 
mycin (fig.2b) indicating the additional contribu- 
tion of Ca*+ sequestration in the absence of 
ionomycin. 
An obvious question is what mechanisms of ac- 
tivating Ca*+ extrusion could be available to the 
cell? Both Ca*+-calmodulin- and PKC-stimulated 
Ca’+ pumping are known [10,12]. The former is 
unlikely as such a mechanism could not account 
for the difference between thrombin and 
ionomycin which both raise [Ca*+]i; also a recent 
report [13] has identified a Ca*+-ATPase in 
platelets similar to that in erythrocyte membranes 
but insensitive to calmodulin. Since thrombin 
causes activation of PKC [4], whereas ionomycin, 
in aspirin-treated platelets, does not [14], we 
looked at the influence of PMA, a direct activator 
of PKC [6] that does not elevate [Ca*+]i in 
fura-2-loaded platelets [l 11, on Ca*+ efflux. 
Typical results are shown in fig.3. Addition of 
PMA 60 s after ionomycin had an effect similar to 
that evoked by thrombin (fig.2b) in enhancing the 
decline in the [Ca*+]i which dropped from near 
1 ,uM to 170 nM within 4 min. These results con- 
cur with previous observations of a PKC-regulated 
Ca*+ efflux mechanism, for example in neutrophils 
[lo] or lymphocytes [15]. This effect of PMA on 
platelet [Ca*‘]i can be considered additional to the 
inhibitory effect of PMA on mobilisation of Ca*+ 
reported in platelets by MacIntyre et al. [9]. Thus, 
protein kinase C appears to interact with platelet 
[Ca*‘]i in at least three ways: it is synergistic to 
promote platelet activation; it inactivates or desen- 
sitises the receptor/Ca*+ gating transduction 
mechanism; and it promotes the return of [Ca*+]i 
to resting levels by stimulating removal of Ca*+ 
from the cell. The basic mechanisms by which 
PKC-stimulated Ca*+ efflux operates could in- 
volve enhanced Na+-Ca2+ exchange or stimulation 
of an ATP-dependent Ca*+ pump in the platelet 
plasma membrane. The question of whether Ca*+ 
pumping from platelets occurs by an Na+-Ca*+ ex- 
changer or a Ca *+-ATPase is contentious and not 
directly addressed by this paper. Our guess is that 
Ca*+-ATPase is more important, a view supported 
by a recent report of such activity in platelets [ 131. 














Fig.3. Stimulation of Ca2+ efflux by PMA. Fura- fluorescence from human platelets suspended in the presence of 
1 mM EGTA and activated by (a) 1 pM ionomycin (IONO) or (b) ionomycin followed by 100 nM phorbol myristate 
acetate (PMA). 
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cent Ca’+-indicator dyes in the presence and 
absence of external Na+ are currently under way in 
our laboratories to analyse further these matters. 
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